This randomized clinical trial evaluates the efficacy and safety of transarterial chemoembolization plus external beam radiotherapy compared with sorafenib in patients with hepatocellular carcinoma and macroscopic vascular invasion.
This single cohort study evaluates the safety and efficacy of pembrolizumab in patients with previously treated advanced gastric or gastroesophageal junction cancer.
This randomized clinical trial assesses whether dose-escalated radiation therapy vs standard dose improves survival for men with intermediate-risk prostate cancer.
This cohort study examines recurrence outcomes in patients with fully resected gastroenteropancreatic neuroendocrine tumors.
This Viewpoint describes how the Cancer Moonshot Initiative provides an opportunity to address cancer disparities and inequities and ways to ensure that its goals are achieved.
This phase 3 randomized clinical trial uses prespecified sensitivity analyses from 1717 men with chemotherapy-naive metastatic castration-resistant prostate cancer to assess the clinical relevance of the Prostate Cancer Working Group 2 definition of radiographic progression-free survival.
This phase 3 randomized clinical trial compares the efficacy and safety of Janus kinase 2 inhibitor pacritinib with that of best available therapy, including ruxolitinib, in patients with myelofibrosis and thrombocytopenia.
This Viewpoint examines the data and circumstances behind the US Food and Drug Administration approval of sunitinib as adjuvant treatment for patients with resected renal cell carcinoma who are at a high risk of relapse.
This article describes the experience of a physician in the Netherlands who has performed euthanasia at the request of a patient.
This National Cancer Database study reports and analyzes the practices and temporal trends for the use of lymph node dissection, chemotherapy, and radiotherapy from 2004 through 2014 for patients with advanced squamous cell carcinoma of the penis.
This cohort study evaluates the prevalence of domain-specific cognitive impairment and its association with overall survival among older patients with blood cancer.
This study reports proof-of-principle early detection of chemotherapeutic-associated skin adverse drug reactions from social health networks using a deep learning–based signal generation pipeline to capture how patients describe cutaneous eruptions.
This review describes all malignant hematology and oncology accelerated approvals from inception of the US Food and Drug Administration accelerated approval program.
This Insights characterizes recent advances and describes a framework for the treatment of advanced non–small cell lung cancer.
This Viewpoint provides an overview of the 2 clinical variants of Mantle cell lymphoma and discusses that the aggressive treatment may not be beneficial for the indolent variant.
This Patient Page provides information of lymphedema, a condition caused by lymph system blockage or damage.